Nolè F - Search Results

1

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Pagani O, Klingbiel D, Ruhstaller T, Nolè F, Eppenberger S, Oehlschlegel C, Bernhard J, Brauchli P, Hess D, Mamot C, Munzone E, Pestalozzi B, Rabaglio M, Aebi S, Ribi K, Rochlitz C, Rothgiesser K, Thürlimann B, von Moos R, Zaman K, Goldhirsch A; Swiss Group for Clinical Cancer Research (SAKK). Pagani O, et al. Among authors: nole f. Ann Oncol. 2017 Feb 1;28(2):305-312. doi: 10.1093/annonc/mdw622. Ann Oncol. 2017. PMID: 27998961 Free article. Clinical Trial.

2

Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: the experience of the National Cancer Institute of Milan.

Colleoni M, Bajetta E, Nelli P, Boni L, Bochicchio AM, Nolè F, Buzzoni R, Celio L, Mazzaferro V, Bonfanti G, et al. Colleoni M, et al. Among authors: nole f. Ann Oncol. 1993 Jun;4(6):489-93. doi: 10.1093/oxfordjournals.annonc.a058560. Ann Oncol. 1993. PMID: 8394736 Free article.

3

Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphoma.

Buzzoni R, Colleoni M, Bajetta E, Nolè F, Nelli P, De Palma CA, de Braud F. Buzzoni R, et al. Among authors: nole f. Ann Oncol. 1993 Mar;4(3):251-3. doi: 10.1093/oxfordjournals.annonc.a058466. Ann Oncol. 1993. PMID: 8471558 Free article. Clinical Trial.

4

Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.

Nolè F, de Braud F, Aapro M, Minchella I, De Pas TM, Zampino MG, Monti S, Andreoni G, Goldhirsch A. Nolè F, et al. Ann Oncol. 1997 Sep;8(9):865-70. doi: 10.1023/a:1008209429204. Ann Oncol. 1997. PMID: 9358936 Free article. Clinical Trial.

5

Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil.

deBraud F, Munzone E, Nolè F, De Pas T, Biffi R, Brienza S, Aapro MS. deBraud F, et al. Among authors: nole f. Am J Clin Oncol. 1998 Jun;21(3):279-83. doi: 10.1097/00000421-199806000-00015. Am J Clin Oncol. 1998. PMID: 9626798 Free article. Clinical Trial.

6

Pre-operative chemotherapy and radiotherapy in breast cancer.

Colleoni M, Nole F, Minchella I, Noberasco C, Luini A, Orecchia R, Veronesi P, Zurrida S, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: nole f. Eur J Cancer. 1998 Apr;34(5):641-5. doi: 10.1016/s0959-8049(97)10091-0. Eur J Cancer. 1998. PMID: 9713267

7

Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Biffi R, et al. Among authors: nole f. Ann Oncol. 1998 Jul;9(7):767-73. doi: 10.1023/a:1008392423469. Ann Oncol. 1998. PMID: 9739444 Free article.

8

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

De Pas T, De Braud F, Orlando L, Nolè F, Munzone E, Zampino MG, Fazio N, Aapro MS, Goldhirsch A. De Pas T, et al. Among authors: nole f. Ann Oncol. 1998 Aug;9(8):917-9. doi: 10.1023/a:1008311901856. Ann Oncol. 1998. PMID: 9789617 Free article. Clinical Trial.

9

Assessment of response in primary chemotherapy for breast cancer.

Colleoni M, Orlando L, Robertson C, Nolé F, Peruzzotti G, Cassano R, Orvieto E, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: nole f. Ann Oncol. 1998 Oct;9(10):1140-1. doi: 10.1023/a:1008425205941. Ann Oncol. 1998. PMID: 9834831 Free article. No abstract available.

10

Prediction of response to primary chemotherapy for operable breast cancer.

Colleoni M, Orvieto E, Nolé F, Orlando L, Minchella I, Viale G, Peruzzotti G, Robertson C, Noberasco C, Galimberti V, Sacchini V, Veronesi P, Zurrida S, Orecchia R, Goldhirsch A. Colleoni M, et al. Among authors: nole f. Eur J Cancer. 1999 Apr;35(4):574-9. doi: 10.1016/s0959-8049(99)00005-2. Eur J Cancer. 1999. PMID: 10492630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters